Sheri Morris, NP
Adult Health · Greenville, SCNPI 1588813745
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 302 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 302 payments — averaging $28.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Abbott$1K
- Lilly USA, LLC$828
- Sanofi-aventis U.S. LLC$706
- Insulet Corporation$533
- Dexcom, Inc.$403
- plus $3K from 28 others
What the payments were for
- Food & beverage$8,28298%
- Education$1942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 40 | $1,862 |
| Abbott | 20 | $1,111 |
| Lilly USA, LLC | 62 | $828 |
| Sanofi-aventis U.S. LLC | 27 | $706 |
| Insulet Corporation | 17 | $533 |
| Dexcom, Inc. | 17 | $403 |
| AstraZeneca(2 entities) | 16 | $343 |
| BETA Bionics, Inc. | 2 | $308 |
| Xeris Pharmaceuticals, Inc. | 13 | $273 |
| Radius Health, Inc. | 7 | $236 |
| Amneal Pharmaceuticals LLC | 14 | $225 |
| Medtronic | 5 | $225 |
| Tandem Diabetes Care, Inc. | 3 | $201 |
| IBSA Pharma Inc. | 10 | $153 |
| Boehringer Ingelheim | 9 | $134 |
| Cequr Corporation | 2 | $132 |
| AbbVie | 8 | $119 |
| Recordati_rare_diseases_inc. | 4 | $90 |
| RGH Enterprises LLC | 1 | $84 |
| Ascensia Diabetes Care US Inc. | 3 | $66 |
| Pfizer | 3 | $54 |
| Ultragenyx Pharmaceutical Inc. | 2 | $45 |
| Chiesi USA, Inc. | 2 | $44 |
| Ascendis Pharma Endocrinology Inc | 2 | $44 |
| Madrigal Pharmaceuticals | 2 | $39 |
| Amgen | 2 | $32 |
| Amphastar Pharmaceuticals, Inc. | 2 | $31 |
| Kyowa Kirin, Inc. | 1 | $30 |
| Soleno Therapeutics, Inc. | 1 | $24 |
| EUSA Pharma (US) LLC | 1 | $22 |
| Sequel Med Tech, LLC | 1 | $22 |
| Corcept Therapeutics | 1 | $21 |
| Mannkind Corporation | 1 | $18 |
| Lifescan, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$848
- FREESTYLE LIBRE 3$574
- FreeStyle Libre 2$232
- MINIMED 780G$143
- t:slim X2 Insulin Pump with Control-IQ$139
- SOLIQUA 100/33$127
- Omnipod$125
- DEXCOM G6 TRANSMITTER$123
- Wegovy$118
- FARXIGA$112
- Tymlos$112
- CeQur Simplicity$103
How this compares
$8,475 in reported general payments places this provider in the 95th percentile of 292 adult health providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 184 | $191,605 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 106 | $146,562 |
| TrulicityDulaglutide | 90 | $117,981 |
| MounjaroTirzepatide | 73 | $98,813 |
| JardianceEmpagliflozin | 63 | $80,915 |
| Tresiba Flextouch U-100Insulin Degludec | 98 | $76,056 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 88 | $64,296 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 67 | $60,190 |
| Humalog Kwikpen U-100Insulin Lispro | 133 | $45,009 |
| Novolog FlexpenInsulin Aspart | 143 | $41,791 |
| FarxigaDapagliflozin Propanediol | 36 | $39,038 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 190 | $38,373 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $37,917 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $32,548 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 46 | $29,151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Humulin N | $828 | $217,978175 claims |
| Novo NordiskOzempic, Novolog | $1,862 | $199,510211 claims |
| Boehringer IngelheimJardiance | $134 | $80,91563 claims |
| AstraZenecaFarxiga | $343 | $39,03836 claims |
| Cequr CorporationCequr Simplicity | $132 | $8,32919 claims |
| AbbVieSynthroid | $119 | $6,53495 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $225 | $1,975266 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 292 adult health providers in South Carolina.
Other adult health in Greenville
- Karen RobertsonGreenville$69K
- Jessica RiceGreenville$15K
- James McKenzieGreenville$8K
- Gary SzetoGreenville$6K
- John SharkeyGreenville$6K
- Sarah BaranskiGreenville$5K
- Brandi RuffoGreenville$4K
- Lynn CurryGreenville$4K
- Christine FranzeseTega Cay$30K
- Michelle PriceCharleston$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.